ARTV logo

Artiva Biotherapeutics, Inc.

ARTV
Healthcare|Biotechnology|US
$4.15
+0.02 (+0.48%)
DCF Value
$0.66
Tangible Book / Share
$8.82
Cash / Share
$8.86

Ownership Breakdown

40.1%
Float
48.9M
Shares Outstanding
19.6M
Float Shares

Major Holders (39)

Combined: 308.9%

Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.

HolderType% of ClassSharesFiledFiling
Peter KolchinskyHC, IN37.90%18,415,956Jul 23, 202613D/G
Rajeev ShahHC, IN37.90%18,415,956Jul 23, 202613D/G
RA Capital Management, L.P.IA, PN37.90%18,415,956Jul 23, 202613D/G
RA Capital Healthcare Fund, L.P.Partnership35.50%17,242,483Jul 23, 202613D/G
Yong-Jun HuhIndividual12.30%5,999,703May 28, 202613D/G
GC CorpHolding company12.30%5,999,703May 28, 202613D/G
Corey GoodmanHC, IN6.30%1,519,971Nov 14, 202413D/G
venBio Global Strategic GP III, Ltd.HC, CO6.30%1,519,971Nov 14, 202413D/G
Robert AdelmanHC, IN6.30%1,519,971Nov 14, 202413D/G
Viking Global Opportunities Parent GP LLCOther5.40%2,604,166May 18, 202613D/G
Viking Global Investors LPPartnership5.40%2,604,166May 18, 202613D/G
Shabet Rose SharonIndividual5.40%2,604,166May 18, 202613D/G
Halvorsen Ole AndreasIndividual5.40%2,604,166May 18, 202613D/G
Goodman Corey SHC, IN4.90%1,198,975May 15, 202513D/G
Venbio Global Strategic GP III, LTDHC, CO4.90%1,198,975May 15, 202513D/G
Adelman Robert JHC, IN4.90%1,198,975May 15, 202513D/G
Venbio Global Strategic GP III, L.P.HC, PN4.90%1,198,975May 15, 202513D/G
venBio Global Strategic Fund III, L.P.Partnership4.90%1,198,975May 15, 202513D/G
Andrew J. SchwabIndividual4.80%2,353,304Aug 10, 202613D/G
Kush ParmarIndividual4.80%2,353,304Aug 10, 202613D/G
VHCP Management III, LLCOther4.20%2,043,596Aug 14, 202613D/G
Bong Y. KohIndividual4.20%2,043,596Aug 14, 202613D/G
Nimish ShahIndividual4.20%2,043,596Aug 14, 202613D/G
VHCP Management EG, LLCOther4.20%2,043,596Aug 14, 202613D/G
Venrock Healthcare Capital Partners III, L.P.Partnership4.20%2,043,596Aug 14, 202613D/G
VHCP Co-Investment Holdings III, LLCOther4.20%2,043,596Aug 14, 202613D/G
Venrock Healthcare Capital Partners EG, L.P.Partnership4.20%2,043,596Aug 14, 202613D/G
Viking Global Opportunities Illiquid Investments Sub-Master LPPartnership3.80%1,822,916May 18, 202613D/G
Viking Global Opportunities GP LLCOther3.80%1,822,916May 18, 202613D/G
Viking Global Opportunities Portfolio GP LLCOther3.80%1,822,916May 18, 202613D/G
GC Cell CorporationCorporation3.30%1,607,734May 28, 202613D/G
5AM Ventures VI, L.P.Partnership2.40%1,171,250Aug 10, 202613D/G
5AM Partners VI, LLCOther2.40%1,171,250Aug 10, 202613D/G
5AM Opportunities II, L.P.Partnership2.40%1,182,054Aug 10, 202613D/G
5AM Opportunities II (GP), LLCOther2.40%1,182,054Aug 10, 202613D/G
BlackRock, Inc.Holding company2.00%485,727Jul 16, 202513D/G
Viking Global Opportunities Vintage IV (Aggregator) LPPartnership1.60%781,250May 18, 202613D/G
Viking Global Opportunities Vintage IV Portfolio GP LLCOther1.60%781,250May 18, 202613D/G
Viking Global Opportunities Vintage IV GP LLCOther1.60%781,250May 18, 202613D/G

Insider Trades (100)

Last 4 quarters: 15,027,657 acquired · 381,541 disposed
InsiderPositionDateTypeSharesPriceValueFiling
Horan ChristopherChief Tech Operations OfficerNov 2, 2026SELL10,423$4.18$43.6KForm 4
Bush JenniferCOO, CLO, Compliance OfficerNov 2, 2026SELL8,439$4.18$35.3KForm 4
Banerjee SubhashisChief Medical OfficerNov 2, 2026SELL1,110$4.18$4.6KForm 4
Aslan Freddirector, officer: Chief Executive OfficerNov 2, 2026SELL62,178$4.18$260.0KForm 4
Aslan Freddirector, officer: Chief Executive OfficerOct 6, 2026SELL23,463$7.20$168.9KForm 4
Horan ChristopherChief Tech Operations OfficerOct 5, 2026SELL10,340$6.84$70.7KForm 4
Bush JenniferCOO, CLO, Compliance OfficerOct 5, 2026SELL8,370$6.84$57.2KForm 4
Banerjee SubhashisChief Medical OfficerOct 5, 2026SELL1,099$6.84$7.5KForm 4
Aslan Freddirector, officer: Chief Executive OfficerOct 5, 2026SELL61,696$6.84$421.8KForm 4
Aslan Freddirector, officer: Chief Executive OfficerSep 15, 2026AWARD110,000——Form 4
Aslan Freddirector, officer: Chief Executive OfficerSep 15, 2026AWARD315,000$8.91$2.8MForm 4
Aslan Freddirector, officer: Chief Executive OfficerSep 10, 2026AWARD45,000——Form 4
Aslan Freddirector, officer: Chief Executive OfficerSep 10, 2026AWARD155,000$10.42$1.6MForm 4
RA CAPITAL MANAGEMENT, L.P.director, 10 percent owner: Sep 10, 2026AWARD16,250$10.42$169.3KForm 4
Stoppel LauradirectorSep 10, 2026AWARD16,250$10.42$169.3KForm 4
Sorg Elaine K.directorSep 10, 2026AWARD16,250$10.42$169.3KForm 4
HOUGEN ELIZABETH LdirectorSep 10, 2026AWARD16,250$10.42$169.3KForm 4
DANIELS BRIANdirectorSep 10, 2026AWARD16,250$10.42$169.3KForm 4
Baker Daniel G.directorSep 10, 2026AWARD16,250$10.42$169.3KForm 4
MOORE ALISONdirectorSep 10, 2026AWARD16,250$10.42$169.3KForm 4
Miralles Gines DiegoPresident & Head of R&DSep 9, 2026AWARD135,000$10.79$1.5MForm 4
Miralles Gines DiegoPresident & Head of R&DSep 9, 2026AWARD45,000——Form 4
Horan ChristopherChief Tech Operations OfficerSep 9, 2026AWARD40,000——Form 4
Horan ChristopherChief Tech Operations OfficerSep 9, 2026AWARD120,000$10.79$1.3MForm 4
Bush JenniferCOO, CLO, Compliance OfficerSep 9, 2026AWARD45,000——Form 4
Bush JenniferCOO, CLO, Compliance OfficerSep 9, 2026AWARD135,000$10.79$1.5MForm 4
Banerjee SubhashisChief Medical OfficerSep 9, 2026AWARD30,000——Form 4
Banerjee SubhashisChief Medical OfficerSep 9, 2026AWARD85,000$10.79$917.1KForm 4
Aslan Freddirector, officer: Chief Executive OfficerSep 8, 2026SELL23,429$10.92$255.7KForm 4
RA CAPITAL MANAGEMENT, L.P.director, 10 percent owner: Sep 8, 2026AWARD13,750$10.88$149.6KForm 4
Stoppel LauradirectorSep 8, 2026AWARD13,750$10.88$149.6KForm 4
Sorg Elaine K.directorSep 8, 2026AWARD13,750$10.88$149.6KForm 4
HOUGEN ELIZABETH LdirectorSep 8, 2026AWARD13,750$10.88$149.6KForm 4
DANIELS BRIANdirectorSep 8, 2026AWARD13,750$10.88$149.6KForm 4
Baker Daniel G.directorSep 8, 2026AWARD13,750$10.88$149.6KForm 4
MOORE ALISONdirectorSep 8, 2026AWARD13,750$10.88$149.6KForm 4
Horan ChristopherChief Tech Operations OfficerSep 3, 2026SELL10,366$11.16$115.6KForm 4
Bush JenniferCOO, CLO, Compliance OfficerSep 3, 2026SELL8,391$11.16$93.6KForm 4
Banerjee SubhashisChief Medical OfficerSep 3, 2026SELL1,100$11.16$12.3KForm 4
Aslan Freddirector, officer: Chief Executive OfficerSep 3, 2026SELL61,888$11.16$690.4KForm 4
Banerjee SubhashisChief Medical OfficerAug 27, 2026OPTION EX.5,306$1.92$10.2KForm 4
Banerjee SubhashisChief Medical OfficerAug 27, 2026SELL8,222$12.01$98.7KForm 4
Banerjee SubhashisChief Medical OfficerAug 27, 2026OPTION EX.5,306$1.92$10.2KForm 4
Banerjee SubhashisChief Medical OfficerAug 18, 2026OPTION EX.429$1.92$823.68Form 4
Banerjee SubhashisChief Medical OfficerAug 18, 2026SELL429$12.00$5.1KForm 4
Banerjee SubhashisChief Medical OfficerAug 18, 2026OPTION EX.429$1.92$823.68Form 4
RA CAPITAL MANAGEMENT, L.P.director, 10 percent owner: Jul 31, 2026BUY24,944$9.93$247.7KForm 4
RA CAPITAL MANAGEMENT, L.P.director, 10 percent owner: Jul 29, 2026BUY20,824$9.99$208.0KForm 4
RA CAPITAL MANAGEMENT, L.P.director, 10 percent owner: Jul 24, 2026BUY41,319$9.99$412.8KForm 4
RA CAPITAL MANAGEMENT, L.P.director, 10 percent owner: Jul 23, 2026BUY59,880$9.96$596.4KForm 4
RA CAPITAL MANAGEMENT, L.P.director, 10 percent owner: Jul 22, 2026BUY84,124$9.93$835.4KForm 4
RA CAPITAL MANAGEMENT, L.P.director, 10 percent owner: Jul 21, 2026BUY120,582$9.55$1.2MForm 4
RA CAPITAL MANAGEMENT, L.P.director, 10 percent owner: Jul 13, 2026BUY6,522$8.94$58.3KForm 4
RA CAPITAL MANAGEMENT, L.P.director, 10 percent owner: Jul 17, 2026BUY7,882$8.95$70.5KForm 4
RA CAPITAL MANAGEMENT, L.P.director, 10 percent owner: Jul 16, 2026BUY152,472$8.93$1.4MForm 4
RA CAPITAL MANAGEMENT, L.P.director, 10 percent owner: Jul 13, 2026BUY6,552$8.94$58.6KForm 4
RA CAPITAL MANAGEMENT, L.P.director, 10 percent owner: Jul 10, 2026BUY15,102$8.97$135.5KForm 4
RA CAPITAL MANAGEMENT, L.P.director, 10 percent owner: Jun 26, 2026BUY1,876$8.98$16.8KForm 4
RA CAPITAL MANAGEMENT, L.P.director, 10 percent owner: Jun 25, 2026BUY31,000$8.88$275.3KForm 4
RA CAPITAL MANAGEMENT, L.P.director, 10 percent owner: Jun 16, 2026BUY124,893$8.89$1.1MForm 4
RA CAPITAL MANAGEMENT, L.P.director, 10 percent owner: Jun 15, 2026BUY15,414$8.99$138.6KForm 4
RA CAPITAL MANAGEMENT, L.P.director, 10 percent owner: Jun 12, 2026BUY391,019$8.57$3.4MForm 4
RA CAPITAL MANAGEMENT, L.P.director, 10 percent owner: Jun 11, 2026BUY548,580$7.91$4.3MForm 4
RA CAPITAL MANAGEMENT, L.P.director, 10 percent owner: Jun 10, 2026BUY103$7.00$721.00Form 4
RA CAPITAL MANAGEMENT, L.P.director, 10 percent owner: Jun 9, 2026BUY479,039$6.91$3.3MForm 4
GC Corp.10 percent ownerMay 11, 2026BUY1,085,069$11.52$12.5MForm 4
GC Corp.10 percent ownerMay 11, 2026BUY347,222$11.52$4.0MForm 4
Raymon HeatherSVP, Research and DevelopmentMay 19, 2026SELL3,095$9.01$27.9KForm 4
Horan ChristopherChief Tech Operations OfficerMay 19, 2026SELL7,002$9.01$63.1KForm 4
Bush JenniferCOO, CLO, Compliance OfficerMay 19, 2026SELL8,790$9.01$79.2KForm 4
Banerjee SubhashisChief Medical OfficerMay 19, 2026SELL7,037$9.01$63.4KForm 4
Aslan Freddirector, officer: Chief Executive OfficerMay 19, 2026SELL27,116$9.01$244.3KForm 4
Miralles Gines DiegoPresident & Head of R&DMay 18, 2026AWARD232,500$9.22$2.1MForm 4
Miralles Gines DiegoPresident & Head of R&DMay 18, 2026AWARD77,500——Form 4
RA CAPITAL MANAGEMENT, L.P.director, 10 percent owner: May 11, 2026BUY6,510,416$11.52$75.0MForm 4
RA CAPITAL MANAGEMENT, L.P.director, 10 percent owner: May 11, 2026BUY2,170,138$0.00$217.01Form 4
Huston Thad AllenChief Financial OfficerMar 10, 2026AWARD220,000——Form 4
Huston Thad AllenFeb 18, 2026OTHER0——Form 4
Sorg Elaine K.directorFeb 18, 2026AWARD27,500$4.15$114.1KForm 4
Sorg Elaine K.Feb 18, 2026OTHER0——Form 4
Raymon HeatherSVP, Research and DevelopmentFeb 15, 2026AWARD46,000——Form 4
Raymon HeatherSVP, Research and DevelopmentFeb 15, 2026TAX W/H1,521$4.00$6.1KForm 4
Horan ChristopherChief Tech Operations OfficerFeb 15, 2026AWARD117,300——Form 4
Horan ChristopherChief Tech Operations OfficerFeb 15, 2026TAX W/H2,187$4.00$8.7KForm 4
Bush JenniferCOO, CLO, Secy, Compliance OffFeb 15, 2026AWARD117,300——Form 4
Bush JenniferCOO, CLO, Secy, Compliance OffFeb 15, 2026TAX W/H3,515$4.00$14.1KForm 4
Banerjee SubhashisChief Medical OfficerFeb 15, 2026AWARD102,000——Form 4
Aslan Freddirector, officer: President and CEOFeb 15, 2026AWARD366,850——Form 4
Aslan Freddirector, officer: President and CEOFeb 15, 2026TAX W/H14,600$4.00$58.4KForm 4
Aslan Freddirector, officer: President and CEODec 15, 2025SELL3,187$6.00$19.1KForm 4
Raymon HeatherSVP, Research and DevelopmentDec 12, 2025AWARD67,253——Form 4
Raymon HeatherSVP, Research and DevelopmentDec 12, 2025DISPOSED18,239$5.14$93.7KForm 4
Raymon HeatherSVP, Research and DevelopmentDec 12, 2025DISPOSED11,399$5.18$59.0KForm 4
Raymon HeatherSVP, Research and DevelopmentDec 12, 2025DISPOSED10,259$13.47$138.2KForm 4
Raymon HeatherSVP, Research and DevelopmentDec 12, 2025DISPOSED14,819$5.01$74.2KForm 4
Horan ChristopherChief Tech Operations OfficerDec 12, 2025AWARD107,156——Form 4
Horan ChristopherChief Tech Operations OfficerDec 12, 2025DISPOSED9,119$5.01$45.7KForm 4
Horan ChristopherChief Tech Operations OfficerDec 12, 2025DISPOSED20,519$13.47$276.4KForm 4
Bush JenniferCOO, CLO, Secy, Compliance OffDec 12, 2025AWARD84,877——Form 4
Bush JenniferCOO, CLO, Secy, Compliance OffDec 12, 2025DISPOSED9,119$5.01$45.7KForm 4